Stock Market & Financial Investment News

News Breaks September 10, 2012 07:26 EDT MYL Mylan risk/reward improved, says Canaccord Canaccord raised Q3 Mylan estimates above consensus due to Epi-Pen strength and Gx Actos. The firm kept its 2013 estimates unchanged due to low visibility and notes a take-out is unlikely. Shares are Hold rated. News For MYL From The Last 14 Days Check below for free stories on MYL the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 11:53 EDT MYL High option volume stocks: UAN MYL ALNY SKS XIDE Subscribe for More Information May 21, 2013 07:35 EDT MYL Mylan: Appellate Court rules in favor of company in patent infringement case Subscribe for More Information May 20, 2013 11:27 EDT MYL Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva Subscribe for More Information May 17, 2013 14:48 EDT MYL Actavis may bid for Warner Chilcott to ward off takeover, Reuters says Subscribe for More Information 13:56 EDT MYL Actavis may purchase Warner Chilcott as takeover defense, Reuters reports Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. 07:31 EDT MYL Mylan launches generic Tricor tablets Subscribe for More Information May 15, 2013 19:37 EDT MYL Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 17:36 EDT MYL Paulson gives quarterly update on stakes Subscribe for More Information 11:42 EDT MYL Mylan launches generic Zomig tablets Subscribe for More Information 07:03 EDT MYL Mylan highly unlikely to acquire Actavis, says Barclays Subscribe for More Information May 14, 2013 13:55 EDT MYL Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says Subscribe for More Information 13:22 EDT MYL Actavis turned down $15B takeover bid from Mylan, Bloomberg reports Subscribe for More Information May 10, 2013 10:00 EDT MYL On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. May 9, 2013 16:34 EDT MYL Mylan initiated with an Underperform at BMO Capital Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.